• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    90.76 Up 0.23(0.25%) May 22, 4:00PM EDT
    |After Hours : 90.75 Down 0.01 (0.01%) May 22, 7:26PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue -   -   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   -   -  
    Operating Expenses
    Research Development56,750  50,149  34,965  28,440  
    Selling General and Administrative7,475  3,741  6,155  6,126  
    Non Recurring -   -   -  400  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (64,225) (53,890) (41,120) (34,966)
    Income from Continuing Operations
    Total Other Income/Expenses Net3,258  1,406  1,770  270  
    Earnings Before Interest And Taxes(60,967)(52,484)(39,350)(34,696)
    Interest Expense2,075  2,604   -   -  
    Income Before Tax(63,042)(55,088)(39,350)(34,696)
    Income Tax Expense102  (181)292  68  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(63,144)(54,907)(39,642)(34,764)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (63,144) (54,907) (39,642) (34,764)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (63,144) (54,907) (39,642) (34,764)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.